Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pascal Machiels

Showing results (91-100 of 164) with videos related to

Pageof 17
Sort By:
Acta Clinica Belgica|May 25, 2018
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinibEmilie Werbrouck, Julie Bastin, Diether Lambrechts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancerAnnelies Debucquoy, Karin Haustermans, Anneleen Daemen, et al.
The Oncologist|April 20, 2016
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate CancerNeeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, et al.
Oral Oncology|April 24, 2012
Distant metastases from head and neck squamous cell carcinoma. Part II. DiagnosisRemco de Bree, Missak Haigentz, Carl E Silver, et al.
Oral Oncology|November 23, 2011
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck diseaseMarc Hamoir, Alfio Ferlito, Sandra Schmitz, et al.
Head & Neck|July 7, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancerJammbe Z Musoro, Corneel Coens, Susanne Singer, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2010
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findingsStéphane Oudard, Olivier Rixe, Benoit Beuselinck, et al.
Oral Oncology|April 21, 2012
Distant metastases from head and neck squamous cell carcinoma. Part III. TreatmentMissak Haigentz, Dana M Hartl, Carl E Silver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancerJean-Pascal Machiels, Filomena Mazzeo, Marylene Clausse, et al.
Clinical Genitourinary Cancer|March 6, 2018
Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase InhibitorsAnnelies Verbiest, Diether Lambrechts, Thomas Van Brussel, et al.
Pageof 17

Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
Acta Clinica Belgica|May 25, 2018
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinibEmilie Werbrouck, Julie Bastin, Diether Lambrechts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancerAnnelies Debucquoy, Karin Haustermans, Anneleen Daemen, et al.
The Oncologist|April 20, 2016
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate CancerNeeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, et al.
Oral Oncology|April 24, 2012
Distant metastases from head and neck squamous cell carcinoma. Part II. DiagnosisRemco de Bree, Missak Haigentz, Carl E Silver, et al.
Oral Oncology|November 23, 2011
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck diseaseMarc Hamoir, Alfio Ferlito, Sandra Schmitz, et al.
Head & Neck|July 7, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancerJammbe Z Musoro, Corneel Coens, Susanne Singer, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2010
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findingsStéphane Oudard, Olivier Rixe, Benoit Beuselinck, et al.
Oral Oncology|April 21, 2012
Distant metastases from head and neck squamous cell carcinoma. Part III. TreatmentMissak Haigentz, Dana M Hartl, Carl E Silver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancerJean-Pascal Machiels, Filomena Mazzeo, Marylene Clausse, et al.
Clinical Genitourinary Cancer|March 6, 2018
Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase InhibitorsAnnelies Verbiest, Diether Lambrechts, Thomas Van Brussel, et al.
Pageof 17